Literature DB >> 21835918

Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.

Max Nunziante1, Kerstin Ackermann, Kim Dietrich, Hanna Wolf, Lars Gädtke, Sabine Gilch, Ina Vorberg, Martin Groschup, Hermann M Schätzl.   

Abstract

A conformational change of the cellular prion protein (PrP(c)) underlies formation of PrP(Sc), which is closely associated with pathogenesis and transmission of prion diseases. The precise conformational prerequisites and the cellular environment necessary for this post-translational process remain to be completely elucidated. At steady state, glycosylated PrP(c) is found primarily at the cell surface, whereas a minor fraction of the population is disposed of by the ER-associated degradation-proteasome pathway. However, chronic ER stress conditions and proteasomal dysfunctions lead to accumulation of aggregation-prone PrP molecules in the cytosol and to neurodegeneration. In this study, we challenged different cell lines by inducing ER stress or inhibiting proteasomal activity and analyzed the subsequent repercussion on PrP metabolism, focusing on PrP in the secretory pathway. Both events led to enhanced detection of PrP aggregates and a significant increase of PrP(Sc) in persistently prion-infected cells, which could be reversed by overexpression of proteins of the cellular quality control. Remarkably, upon proteasomal impairment, an increased fraction of misfolded, fully glycosylated PrP molecules traveled through the secretory pathway and reached the plasma membrane. These findings suggest a novel pathway that possibly provides additional substrate and template necessary for prion formation when protein clearance by the proteasome is impaired.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835918      PMCID: PMC3190803          DOI: 10.1074/jbc.M111.272617

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.

Authors:  B Caughey; G J Raymond
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

2.  Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation.

Authors:  A Taraboulos; M Rogers; D R Borchelt; M P McKinley; M Scott; D Serban; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells.

Authors:  N Daude; S Lehmann; D A Harris
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

4.  Structural clues to prion replication.

Authors:  F E Cohen; K M Pan; Z Huang; M Baldwin; R J Fletterick; S B Prusiner
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

5.  Chemical chaperones interfere with the formation of scrapie prion protein.

Authors:  J Tatzelt; S B Prusiner; W J Welch
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins.

Authors:  F E Ware; A Vassilakos; P A Peterson; M R Jackson; M A Lehrman; D B Williams
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

7.  Synthesis and trafficking of prion proteins in cultured cells.

Authors:  A Taraboulos; A J Raeber; D R Borchelt; D Serban; S B Prusiner
Journal:  Mol Biol Cell       Date:  1992-08       Impact factor: 4.138

8.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins.

Authors:  D A Butler; M R Scott; J M Bockman; D R Borchelt; A Taraboulos; K K Hsiao; D T Kingsbury; S B Prusiner
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.

Authors:  A Taraboulos; M Scott; A Semenov; D Avrahami; L Laszlo; S B Prusiner; D Avraham
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

10.  Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells.

Authors:  D R Borchelt; M Scott; A Taraboulos; N Stahl; S B Prusiner
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

View more
  31 in total

1.  The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein.

Authors:  Mauricio Torres; Danilo B Medinas; José Manuel Matamala; Ute Woehlbier; Víctor Hugo Cornejo; Tatiana Solda; Catherine Andreu; Pablo Rozas; Soledad Matus; Natalia Muñoz; Carmen Vergara; Luis Cartier; Claudio Soto; Maurizio Molinari; Claudio Hetz
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

2.  Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease.

Authors:  Jin Zhang; Xiao-Ping Dong
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

3.  XBP1 and PERK Have Distinct Roles in Aβ-Induced Pathology.

Authors:  Kuan-Chung Cheng; Hsueh-Cheng Chiang
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

4.  Prion and Prion-like Diseases in Humans: Poster Abstracts.

Authors: 
Journal:  Prion       Date:  2013 Apr/May       Impact factor: 3.931

5.  Disruption of glycosylation enhances ubiquitin-mediated proteasomal degradation of Shadoo in Scrapie-infected rodents and cultured cells.

Authors:  Jin Zhang; Yan Guo; Wu-Ling Xie; Yin Xu; Ke Ren; Qi Shi; Bao-Yun Zhang; Cao Chen; Chan Tian; Chen Gao; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-01-04       Impact factor: 5.590

6.  Unfolding the promise of translational targeting in neurodegenerative disease.

Authors:  Thomas M Drake
Journal:  Neuromolecular Med       Date:  2015-02-20       Impact factor: 3.843

7.  FBXW7-Induced MTOR Degradation Forces Autophagy to Counteract Persistent Prion Infection.

Authors:  Yin Xu; Chan Tian; Jing Sun; Jin Zhang; Ke Ren; Xue-Yu Fan; Ke Wang; Hui Wang; Yu-E Yan; Cao Chen; Qi Shi; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

8.  Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis.

Authors:  Maurizio Sorice; Vincenzo Mattei; Vincenzo Tasciotti; Valeria Manganelli; Tina Garofalo; Roberta Misasi
Journal:  Prion       Date:  2012-07-30       Impact factor: 3.931

Review 9.  Is tau ready for admission to the prion club?

Authors:  Garth F Hall; Brian A Patuto
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

10.  De novo prion aggregates trigger autophagy in skeletal muscle.

Authors:  Shivanjali Joshi-Barr; Cyrus Bett; Wei-Chieh Chiang; Margarita Trejo; Hans H Goebel; Beata Sikorska; Pawel Liberski; Alex Raeber; Jonathan H Lin; Eliezer Masliah; Christina J Sigurdson
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.